Equillium (EQ) Liabilities and Shareholders Equity (2017 - 2026)

Equillium (EQ) reported Liabilities and Shareholders Equity of $63.1 million for Q1 2026, up 277.09% year-over-year from $16.7 million in Q1 2025, and up 97.83% quarter-over-quarter from $31.9 million in Q4 2025.

Equillium (EQ) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

Equillium (EQ) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $63.1 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $63.1 million, up 277.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $141.9 million (up 18.57% YoY), and the FY2025 annual result was $31.9 million, up 24.54% from the prior year.
  • Liabilities and Shareholders Equity advanced to $63.1 million in Q1 2026 per EQ's latest filing, from $31.9 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $78.4 million in Q4 2022 and troughed at $12.4 million in Q2 2025.
  • A 5-year average of $47.4 million and a median of $48.6 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity tumbled 71.07% in 2025, then soared 277.09% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $78.4 million in 2022, then sank by 35.57% to $50.5 million in 2023, then slumped by 49.33% to $25.6 million in 2024, then climbed by 24.54% to $31.9 million in 2025, then jumped by 97.83% to $63.1 million in 2026.
  • Business Quant data shows EQ's Liabilities and Shareholders Equity at $63.1 million in Q1 2026, $31.9 million in Q4 2025, and $34.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Equillium 293.17 Mn 232.78 Mn - 63.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 63.08 Mn
Dec 31, 2025 31.89 Mn
Sep 30, 2025 34.51 Mn
Jun 30, 2025 12.40 Mn
Mar 31, 2025 16.73 Mn
Dec 31, 2024 25.60 Mn
Sep 30, 2024 34.46 Mn
Jun 30, 2024 42.86 Mn
Mar 31, 2024 43.60 Mn
Dec 31, 2023 50.53 Mn
Sep 30, 2023 55.23 Mn
Jun 30, 2023 58.76 Mn
Mar 31, 2023 71.79 Mn
Dec 31, 2022 78.42 Mn
Sep 30, 2022 48.63 Mn
Jun 30, 2022 62.47 Mn
Mar 31, 2022 74.24 Mn
Dec 31, 2021 85.41 Mn
Sep 30, 2021 92.47 Mn
Jun 30, 2021 99.84 Mn